Europe

May 16, 2018
Pharmaceutical Executive
Pair of EU meetings, while well-meant, offered little action and beg the question—what’s the true merit in working together?
May 03, 2018
Despite the uncertainty, there is plenty of work to be done to reduce risk in supply chains ahead of the UK’s exit from the European Union, write Johnathon Marshall and Chris Cartmell.
Mar 21, 2018
Looking back at the agenda of a 1985 EFPIA conference, Reflector sees that, three decades on, the European drug industry is still seeking a pill for its own ills.
Mar 16, 2018
James Burt, Accord Healthcare’s EVP, Europe and MENA, outlines his optimistic vision for the UK and Europe post-Brexit and the challenges of retaining a company culture amid major growth.
Feb 20, 2018
In the coming weeks, the EU will decide if the degree of protection offered to drug firms by research incentives such as the SPC are really in the interests of patients and society. Reflector reports.
Feb 06, 2018
Pharmaceutical Executive
Julian Upton assembles a few rare slivers of positivity on UK pharma's future.
Jan 30, 2018
As the Ukranian healthcare market opens up to more public and private competition, it will become more attractive for investors — both Ukrainian and foreign, write Lana Sinichkina and Anna Zorya.
Jan 24, 2018
Reflector reports on the EU's legislative move to push the fifty or so national and regional HTA organizations in Europe towards greater cooperation.
Dec 10, 2017
Pharmaceutical Executive
New action plan urges tighter alignment of public health policy with the development of targeted therapies.
Nov 17, 2017
Allergan's CEO Brent Saunders explains why the European Medicines Agency should choose Dublin as its headquarters after leaving London.
native1_300x100
lorem ipsum